By Ken Thorpe
February 22, 2024
Law360
In December, the White House issued a new policy framework that could have devastating effects on access to cutting-edge drugs. The proposal would radically reinterpret a 43-year-old law to let the government march in and take patents
February 8, 2024 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement in advance of today’s U.S. Senate Committee on Health, Education, Labor & Pensions hearing on prescription drugs:
“Reducing health care costs both for
February 1, 2024 (Washington, D.C.) Today the Partnership to Fight Chronic Disease (PFCD) applauded Representatives Greg Murphy (R-NC), Don Davis (D-NC), and Brett Guthrie (R-KY) for their leadership in support of millions of Americans living with chronic disease and the introduction of the
Dramatic increases in maternal mortality linked to impacts of chronic disease
October 24, 2023 (SAN DIEGO, CA) Today the Partnership to Fight Chronic Disease (PFCD) co-hosted a community seminar on the increasing connection of chronic disease and Black maternal health with California
Achieving promised savings for government program will inevitably restrict patient access to decrease utilization of lifesaving medications
August 29, 2023 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement today in response to the Centers
Hartford Courant
8/15/23
The Biden administration just announced a new initiative to improve cancer outcomes in low-income communities across the United States.[1] It's sorely needed. Research shows cancer mortality is more than 10% higher in communities experiencing persistent
Lowering Drug Costs for Families Act misses the mark on making savings a reality for patients
July 26, 2023 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement today in response to the “Lowering Drug Costs for American Families Act
Latest FDA approval sparks CMS launch of Alzheimer’s registry but questions remain
July 7, 2023 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement in response to the U.S. Food and Drug Administration (FDA) decision to grant traditional
June 2, 2023 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement in response to the Centers for Medicare and Medicaid Services (CMS) announcement related to the current National Coverage Determination (NCD) with Coverage with Evidence Development (CED
5/17/2023
https://dcjournal.com/the-mysteries-of-making-savings-a-reality-at-the-pharmacy-counter/
One way or another, it looks like the drug supply chain middlemen known as pharmacy benefit managers, or PBMs, are going to be pulled out of the shadows. And that’s good news for